← Open Payments lookup

DAVID FAWKS: Open Payments

NPI 1922094937 · VENICE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,789 in 115 payments from 22 companies in 2025. Trend: 2023 $1,761 · 2024 $2,311 · 2025 $2,789

Food & beverage: $2,789
CompanyPaymentsAmount
Neurocrine BioSciences, Inc.17$468
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)11$395
Alkermes, Inc.11$352
ABBVIE INC.11$203
Otsuka America Pharmaceutical, Inc.11$178
E.R. Squibb & Sons, L.L.C.4$149
Lundbeck LLC6$139
Vanda Pharmaceuticals Inc.5$120
Takeda Pharmaceuticals U.S.A., Inc.5$116
Axsome Therapeutics, Inc.5$113

Products named: INGREZZA, CAPLYTA, REXULTI, VRAYLAR, ARISTADA, LYBALVI, COBENFY, TRINTELLIX.

Industry payments across FL — which companies pay providers there.